In the following article the topic of Chlormerodrin will be addressed from different perspectives, with the aim of providing a complete and detailed view of this topic. Fundamental aspects will be analyzed, different opinions will be explored and specific cases will be presented that exemplify the importance and relevance of Chlormerodrin today. Likewise, relevant data, updated statistics will be presented and the impact that Chlormerodrin has had in various areas of society will be delved into. Through this article we aim to provide the reader with solid and up-to-date knowledge about Chlormerodrin, so that they can thoroughly understand this topic and form their own opinion about it.
![]() | |
Names | |
---|---|
IUPAC name
3-carbamoylamino-2-methoxypropylmercury(II) chloride
| |
Systematic IUPAC name
3-chloro-mercura-2-methoxy propylurea | |
Other names
| |
Identifiers | |
3D model (JSmol)
|
|
ECHA InfoCard | 100.000.483 |
PubChem CID
|
|
| |
Properties | |
C5H11ClHgN2O2 | |
Molar mass | 367.20 g·mol−1 |
Appearance | Solid |
Melting point | 152.5 °C (306.5 °F; 425.6 K) |
11 g/L | |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Renal mercury poisoning |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
|
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | Medical Encyclopedia |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.000.483 |
Chemical and physical data | |
Formula | C5H11ClHgN2O2 |
Molar mass | 367.20 g·mol−1 |
3D model (JSmol) | |
| |
|
Chlormerodrin is a mercurial diuretic commercially traded from 1952[1] until 1974[2] that was once used to treat patients with heart failure,[3] but is no longer in widespread use.[4] The radiolabelled form (197Hg & 203Hg) had also been used for medical imaging of the kidney and brain[5][6] and the 197Hg form was even considered a contender for 99mTc by some physicians,[7] but was ultimately discontinued by the FDA in 1989.[8]